Related references
Note: Only part of the references are listed.Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
Vincenzo Carafa et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial-mesenchymal transition in ovarian carcinoma
Tong Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells
Tim Prozorovski et al.
NEUROSCIENCE LETTERS (2019)
SIRT1 (rs3740051) role in pituitary adenoma development
Rasa Liutkeviciene et al.
BMC MEDICAL GENETICS (2019)
Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas
Isabella P. P. Grande et al.
PITUITARY (2018)
Reduced expression of SIRT1 and SOD-1 and the correlation between these levels in various regions of the brains of patients with Alzheimer's disease
Kun Cao et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population
Yutian Kan et al.
CANCER CELL INTERNATIONAL (2018)
High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions
Birsen Elibol et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells
Weijin Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Association of FGFR2 rs2981582, SIRT1 rs12778366, STAT3 rs744166 gene polymorphisms with pituitary adenoma
Brigita Glebauskiene et al.
ONCOLOGY LETTERS (2017)
SIRT I gene polymorphisms and risk of lung cancer
Yanbo Lv et al.
CANCER MANAGEMENT AND RESEARCH (2017)
SIRT1 gene polymorphisms and its protein level in colorectal cancer
Olfat Gamil Shaker et al.
GENE REPORTS (2017)
Anatomy, Physiology, and Laboratory Evaluation of the Pituitary Gland
Gregory K. Hong et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2016)
Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians
Sherine M. Rizk et al.
PLOS ONE (2016)
Spindle Cell Oncocytomas and Granular Cell Tumors of the Pituitary Are Variants of Pituicytoma
Ozgur Mete et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Histone deacetylase inhibitors suppress immune activation in primary mouse microglia
Vishnu Kannan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro
Jing-Xin Ma et al.
NEUROPATHOLOGY (2013)
Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer
Sang Jae Noh et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
Hsieh-Cheng Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
V. Byles et al.
ONCOGENE (2012)
Pathogenesis of pituitary tumors
Shlomo Melmed
NATURE REVIEWS ENDOCRINOLOGY (2011)
Balance between SIRT1 and DBC1 expression is lost in breast cancer
Ji-Youn Sung et al.
CANCER SCIENCE (2010)
SIRT1 Regulates Thyroid-Stimulating Hormone Release by Enhancing PIP5Kγ Activity through Deacetylation of Specific Lysine Residues in Mammals
Sayaka Akieda-Asai et al.
PLOS ONE (2010)
Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
Eun Jung Cha et al.
CLINICAL CANCER RESEARCH (2009)
Expression and prognostic significance of SIRT1 in ovarian epithelial tumours
Kyu Yun Jang et al.
PATHOLOGY (2009)
SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma
Kyu Yun Jang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
SIRT1 is significantly elevated in mouse and human prostate cancer
Derek M. Huffman et al.
CANCER RESEARCH (2007)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
WY Chen et al.
CELL (2005)
Mammalian SIRT1 represses forkhead transcription factors
MC Motta et al.
CELL (2004)
The prevalence of pituitary adenomas - A systematic review
S Ezzat et al.
CANCER (2004)
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
HY Cohen et al.
SCIENCE (2004)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
